Hologic

Hologic inks consent agreement with U.S. Federal Trade Commission regarding Mammotest

Published in Telemedicine Law Weekly, August 12th, 2006

Hologic, Inc., (HOLX), a provider of diagnostic and digital imaging systems directed towards women's health, announced it has signed a consent agreement with the U.S. Federal Trade Commission (FTC) that would resolve Hologic's dispute with the FTC regarding Hologic's acquisition of the Mammotest prone bed breast biopsy system intellectual property.

The intellectual property was acquired as part of the mammography intellectual property assets purchased from Fischer Imaging Corp. in September 2005.

The consent agreement remains subject to final approval by the FTC after a 30-day public comment period.

As part of the consent...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly

Source: Telemedicine Law Weekly (2006-08-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry